Sale!

SNTA1 Gene Long QT Syndrome Type 12 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The SNTA1 Gene Long QT Syndrome Type 12 NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the SNTA1 gene associated with Long QT Syndrome Type 12. This comprehensive genetic analysis helps detect inherited cardiac arrhythmia disorders that can lead to sudden cardiac death. Using Next-Generation Sequencing (NGS) technology, the test provides precise identification of genetic variants affecting heart rhythm regulation. Individuals with family history of sudden cardiac events, unexplained fainting spells, or abnormal ECG findings should consider this test. Early detection enables proactive management and preventive strategies. The test costs $500 USD and includes genetic counseling to help interpret results and understand familial implications.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

SNTA1 Gene Long QT Syndrome Type 12 NGS Genetic DNA Test

Comprehensive Introduction to SNTA1 Genetic Testing

The SNTA1 Gene Long QT Syndrome Type 12 NGS Genetic DNA Test represents a breakthrough in cardiac genetic diagnostics, offering precise detection of mutations associated with Long QT Syndrome Type 12. This inherited cardiac condition affects the heart’s electrical system, potentially leading to life-threatening arrhythmias and sudden cardiac death. Our advanced testing methodology provides crucial insights for individuals and families affected by this genetic disorder.

What This Test Measures and Detects

This sophisticated genetic analysis specifically targets the SNTA1 gene using Next-Generation Sequencing technology to identify:

  • Pathogenic variants in the SNTA1 gene associated with Long QT Syndrome Type 12
  • Genetic mutations affecting cardiac sodium channel function
  • Inherited abnormalities in heart rhythm regulation
  • Specific nucleotide changes and structural variations
  • Both known and novel genetic variants with clinical significance

Who Should Consider SNTA1 Genetic Testing

Clinical Indications and Symptoms

This test is recommended for individuals experiencing:

  • Unexplained fainting spells or syncope episodes
  • Family history of sudden cardiac death or unexplained death
  • Abnormal electrocardiogram (ECG) findings showing prolonged QT interval
  • Recurrent palpitations or irregular heartbeats
  • Previous diagnosis of Long QT Syndrome without genetic confirmation
  • Family members of individuals with confirmed SNTA1 mutations
  • Unexplained seizures or cardiac events during physical exertion

Significant Benefits of Genetic Testing

Undergoing SNTA1 genetic testing provides numerous advantages:

  • Early Risk Identification: Detect genetic predisposition before symptoms manifest
  • Personalized Treatment Planning: Enable targeted therapeutic interventions
  • Family Screening: Identify at-risk relatives for preventive care
  • Reproductive Planning: Inform family planning decisions
  • Reduced Anxiety: Provide clarity and eliminate diagnostic uncertainty
  • Improved Outcomes: Enable proactive management strategies

Understanding Your Test Results

Interpretation Guidance

Your genetic test results will fall into one of several categories:

  • Positive Result: Indicates presence of a known pathogenic variant requiring cardiac specialist consultation and family screening
  • Negative Result: No mutation detected, though clinical monitoring may still be recommended based on family history
  • Variant of Uncertain Significance: Requires ongoing monitoring and periodic re-evaluation as research advances
  • Benign Variant: Genetic change not associated with increased disease risk

Test Details and Pricing

Test Component Details
Test Name SNTA1 Gene Long QT Syndrome Type 12 NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements and Preparation

Before undergoing testing, patients should provide:

  • Complete clinical history and cardiac evaluation records
  • Family medical history with emphasis on cardiac conditions
  • Previous ECG and cardiac testing results
  • Participation in genetic counseling session to create detailed pedigree chart
  • Informed consent understanding test implications and potential outcomes

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic counselors and cardiac specialists ensures comprehensive care regardless of your location.

Take Action for Your Cardiac Health

Don’t wait to address potential genetic cardiac risks. Our team of genetic specialists and cardiologists are ready to provide the expert care and guidance you need. Early detection through genetic testing can be life-saving for you and your family members.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your SNTA1 Gene Long QT Syndrome Type 12 NGS Genetic DNA Test. Take the first step toward understanding your cardiac genetic health with confidence and clarity.